DPW
AMRX icon

DiNuzzo Private Wealth’s Amneal Pharmaceuticals AMRX Stock Holding History

DiNuzzo Private Wealth’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$451 Buy
26
+1
+4% +$14 ﹤0.01% 1124
2026
Q1 		$311 Hold
25
– – ﹤0.01% 1184
2025
Q4 		$315 Buy
25
+3
+14% +$34 ﹤0.01% 1190
2025
Q3 		$211 Hold
22
– – ﹤0.01% 1257
2025
Q2 		$178 Buy
22
+19
+633% +$143 ﹤0.01% 1263
2025
Q1 		$26 Hold
3
– – ﹤0.01% 1357
2024
Q4 		$24 Buy
+3
New +$25 ﹤0.01% 1394

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

DiNuzzo Private Wealth's AMRX Position: Q2 2026 in Review

DiNuzzo Private Wealth increased its Amneal Pharmaceuticals (AMRX) stake by 4% in Q2 2026, buying an estimated $14 and bringing the position to 26 shares worth $451. The position accounts for ﹤0.01% of the portfolio, ranked #1124.

DiNuzzo Private Wealth first reported a position in AMRX in Q4 2024 and has held it in 7 quarters since. 308 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • DiNuzzo Private Wealth held 26 shares of Amneal Pharmaceuticals worth $451 as of Q2 2026.
  • DiNuzzo Private Wealth bought 1 Amneal Pharmaceuticals share in Q2 2026, an estimated $14.
  • Amneal Pharmaceuticals made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q2 2026, its #1124 holding.
  • DiNuzzo Private Wealth first reported a position in Amneal Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 308 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q2 2026, filed 10 Jul 2026.